Log in to your Inderes Free account to see all free content on this page.
Virogates
12.60 DKK
-3.08 %
Less than 1K followers
VIRO
First North Denmark
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
-3.08 %
-17.11 %
+26.51 %
+40.31 %
+18.87 %
+4.13 %
-61.00 %
-77.30 %
-80.89 %
Virogates is active in medical technology. The company is active in research and development of biomarkers and diagnostic instruments for the healthcare industry. The products are sold under various brands and are used in the identification, analysis and further treatment of diseases, primarily cardiovascular diseases, cancer and neurological diseases. The company was established in 2001 and is headquartered in Birkerød.
Read moreMarket cap
116.98M DKK
Turnover
48.87K DKK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
26.3.
2026
Annual report '25
23.4.
2026
General meeting '26
7.5.
2026
Interim report Q1'26
All
Press releases
3rd party
ShowingAll content types
ViroGates announces financial guidance for 2026
ViroGates’ capital raise of DKK 19.3 million and issue of 1,547,412 shares have been registered and settled
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio